Use of an immunoregulatory NK cell population for monitoring the efficacy of anti-IL-2R antibodies in multiple sclerosis patients

Details for Australian Patent Application No. 2010286427 (hide)

Owner Abbott Biotherapeutics Corp .

Inventors Sheridan III, James Peter

Agent Davies Collison Cave

Pub. Number AU-A-2010286427

PCT Pub. Number WO2011/026117

Priority 61/238,353 31.08.09 US

Filing date 31 August 2010

Wipo publication date 3 March 2011

International Classifications

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/026117 Priority application(s): WO2011/026117

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010286429-Method and apparatus for simultaneous localization and mapping of mobile robot environment

2010286418-Travel reservations using a common model